|
Defining mechanisms and targets in Wnt addicted human malignancies (PQ22)
|
5R01CA170702-04
|
$351,713
|
$351,713
|
AARONSON, STUART
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S1
|
|
$0
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S2
|
$64,741
|
$14,567
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S3
|
$229,232
|
$51,577
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S4
|
$593,811
|
$133,607
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S5
|
$917,771
|
$206,498
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S6
|
$68,356
|
$15,380
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S7
|
$778,576
|
$175,180
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S8
|
$73,651
|
$16,571
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
5U10CA180884-02
|
$400,000
|
$80,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-02
|
$24,080,302
|
$5,418,068
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
5U10CA180791-02
|
$737,200
|
$73,720
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Genetically-Modified Neural Stem Cell Based Virotherapy for Invasive Gliomas
|
5R00CA160775-04
|
$239,075
|
$239,075
|
AHMED, ATIQUE
|
UNIVERSITY OF CHICAGO
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Sit
|
5U10CA180790-02
|
$1,295,864
|
$194,380
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
Oncohistones: Role of Histone H3 Mutations in the Oncogenesis of Pediatric Cancer
|
1P01CA196539-01
|
$2,023,721
|
$2,023,721
|
ALLIS, CHARLES
|
ROCKEFELLER UNIVERSITY
|
|
Multi-Tensor Decompositions for Personalized Cancer Diagnostics and Prognostics
|
1U01CA202144-01
|
$607,358
|
$303,679
|
ALTER, ORLY
|
UNIVERSITY OF UTAH
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144 - 07130
|
$1,717,771
|
$17,178
|
Alter, Blanche
|
DCEG (NCI)
|
|
NCTN Deep South Research Consortium
|
3U10CA180855-02S1
|
$199,999
|
$2,500
|
ALVAREZ, RONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
NCTN Deep South Research Consortium
|
5U10CA180855-02
|
$497,800
|
$6,223
|
ALVAREZ, RONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$768,848
|
$76,885
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
The role of ATRX and H3.3 mutations in pediatric glioblastoma
|
5F32CA189741-02
|
$54,194
|
$54,194
|
ANASTAS, JAMIE
|
CHILDREN'S HOSPITAL CORPORATION
|
|
Annexin A2 as a Novel Enhancer of Tumor-Associated Antigen Processing
|
5F30CA167912-03
|
$48,120
|
$48,120
|
ANDERSEN, BRIAN
|
UNIVERSITY OF MINNESOTA
|
|
Quantify treatment response in IDH1 mutant glioma patients with metabolic MRI
|
5K22CA178269-02
|
$200,418
|
$200,418
|
ANDRONESI, OVIDIU
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-02
|
$557,728
|
$27,886
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Understanding Mechanisms of Resistance to Anti-angiogenic Treatments
|
5R01CA160216-04
|
$365,426
|
$365,426
|
ARBAB, ALI
|
GEORGIA REGENTS UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA082103-17S2
|
$50,000
|
$9,000
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S3
|
$124,967
|
$22,494
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S4
|
$199,969
|
$35,994
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S5
|
$158,600
|
$28,548
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
5P30CA082103-17
|
$7,292,969
|
$1,312,734
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumor
|
5R01CA155769-05
|
$348,600
|
$348,600
|
BADIE, BEHNAM
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Novel Cell Delivery Method for Brain Tumor Therapy
|
5R21CA189223-02
|
$230,375
|
$230,375
|
BADIE, BEHNAM
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Identifying vulnerabilities and therapeutic targets in Glioma Stem Cells
|
1K22CA197053-01
|
$200,880
|
$200,880
|
BADR, CHRISTIAN
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Identify OTX2-interacting proteins repressing differentiation in medulloblastoma
|
5R03CA178118-02
|
$81,000
|
$81,000
|
BAI, RENYUAN
|
JOHNS HOPKINS UNIVERSITY
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S1
|
$37,429
|
$749
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S2
|
$125,000
|
$2,500
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-41
|
$4,288,496
|
$85,770
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Meso-plex miRNA and protein profiling for cancer diagnostics using chip-integrate
|
5R33CA177462-03
|
$319,852
|
$319,852
|
BAILEY, RYAN
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
|
Normal and Neoplastic Growth in the Brain
|
2P01CA096832-11A1
|
$2,082,888
|
$2,082,888
|
BAKER, SUZANNE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cooperating Pathways in Gliomagenesis
|
5R01CA188516-02
|
$369,350
|
$369,350
|
BAKER, SUZANNE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Functional Inhibition of Deubiquitylase HAUSP to Disrupt Glioblastoma Stem Cells
|
1R01CA184090-01A1
|
$362,569
|
$362,569
|
BAO, SHIDENG
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Targeting Brain Tumor Stem Cells In The Hypoxic Microenvironment
|
1R01CA187780-01A1
|
$362,569
|
$362,569
|
BAR, ELI
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
|
1R01CA194404-01
|
$332,363
|
$132,945
|
BARBER, GLEN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Platform for MR-Guided Neurotherapeutic Drug Delivery
|
2R44CA177205-02
|
$938,975
|
$938,975
|
BARKER, EDWARD
|
INSERT, INC.
|
|
Interplay between intrinsic and extrinsic force and glioma aggression
|
5F32CA174319-03
|
$8,101
|
$8,101
|
BARNES, JAMES
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-02
|
$1,549,280
|
$77,464
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Training Program in Nervous System Tumors
|
5K12CA090354-15
|
$774,522
|
$774,522
|
BATCHELOR, TRACY
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Clinical and Molecular Studies of Malignant Brain Tumors
|
5K24CA125440-09
|
$185,972
|
$139,479
|
BATCHELOR, TRACY
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
SPORE: Targeted Therapies for Glioma
|
5P50CA165962-03
|
$2,166,955
|
$2,166,955
|
BATCHELOR, TRACY
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Angiogenesis-targeting therapy for glioblastoma
|
5R01CA129371-08
|
$575,734
|
$575,734
|
BATCHELOR, TRACY
|
MASSACHUSETTS GENERAL HOSPITAL
|
Total relevant funding to Brain for this search: $202,158,714
|